Stay updated on Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Enrollment status updated to indicate recruitment has ended. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, with the revision label changed to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T17:04:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added and Revision: v3.5.4 was removed, indicating the page's revision tag was updated. This reflects a new revision deployment affecting the page's metadata rather than its content.
    Difference
    0.1%
    Check dated 2026-06-06T17:05:23.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4 on the page, indicating a new version of the page. This is a minor, administrative update rather than a substantive change to the study content.
    Difference
    0.1%
    Check dated 2026-05-16T09:25:40.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The publications section citation for the related Oncologist article was updated to reflect the finalized issue date/details instead of an online-ahead-of-print entry. The page revision/version label was also updated (v3.5.2 to v3.5.3).
    Difference
    0.1%
    Check dated 2026-04-24T22:23:38.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T13:55:37.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Added publication reference: Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Semin Cancer Biol. 2025;109:101-124 (Epub Jan 23, 2025).
    Difference
    0.1%
    Check dated 2026-04-03T05:28:53.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.